MyNeuroskin.com and our Inbound Call Centre Are Taking Orders

LUMBY, BC, Sept. 3 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, confirms today that their nationwide DRTV commercials for Neuroskin(R) Psoriasis Relief are receiving good responses via call center and website hits.

Lorie Campbell-Farley, President and COO of avVaa World Health Care Products Inc, commented, "We launched our DRTV Neuroskin(R)Psoriasis Relief test commercials on August 24. 29 spots were shown last week, and 13 are showing this week. At the end of the test period we will evaluate all the data and see where we are getting the most bang for our buck."

Both the web site and call center are taking orders, and the early information shows a positive response. "We are excited so far, and will evaluate the full results of the test beginning next week," stated Mrs. Campbell-Farley. "Over the following two weeks, we will be releasing our results, as well as sharing our next steps."

avVaa World Health Care Products Inc. is projecting that it will add $6.38 million in revenue growth in the next 12 months, $19.75 million in the following 12 months, and $29.63 million in the third year.

This week we are working on getting our financials updated, and will be back to Pink Sheet Limited status within 14 days. We also are targeting to be fully reporting on Pink sheets with all disclosures within 60 days.

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R)) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.

Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved.

Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

SOURCE avVaa World Health Care Products